Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone during NTZ to FTY washout in MS
NCT02769689Phase 4Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jun 2019
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in multiple sclerosis (MS), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02769689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769689.